Services that help makers of FDA-cleared brain-stimulation headsets and mental health apps get into clinics, win insurance payment, and sell to consumers.
Consumer neurotech distribution & reimbursement
With Wired reporting a new FDA‑cleared headset for depression is now available in the US and sold at consumer prices, makers face a sudden push to move beyond gadget sales. Services that secure clinic partnerships, navigate insurance payment, and build consumer channels can turn this device into covered care rather than a standalone product.
Projected Score
as a side gig ☆☆☆☆☆ (0/5)
no money or audience ★☆☆☆☆ (1/5)
with both ★★★☆☆ (3/5)
Want this one researched? Commission the full dossier for $15: we research and write it, and you read it first. Then you choose — pay more to keep it exclusive, or do nothing and it goes public on this site. The score above is our forecast for a dossier we haven’t written yet.
The news behind it
- Sep 15, 2026 Wired: A New Headset to Help With Depression Is Now Available in the US
